Product information

From Health Canada

New search

Current status:

Marketed

Current status date:

2013-08-20

Original market date: See footnote 1

2007-12-20

Product name:

DECONGEST NASAL

Description:

SPRAY

DIN:

02300265 Electronic product monograph is not available

Company: 

TEVA CANADA LIMITED
30 Novopharm Court
Toronto
Ontario
Canada  M1B 2K9

Class: 

Human

Dosage form(s):

Solution

Route(s) of administration:

Nasal

Number of active ingredient(s):

1

Schedule(s):

OTC  

Biosimilar Biologic Drug:

No

American Hospital Formulary Service (AHFS): See footnote 3

52:32.00   VASOCONSTRICTORS

Anatomical Therapeutic Chemical (ATC): See footnote 4

R01AA07  XYLOMETAZOLINE

Active ingredient group (AIG) number:See footnote 5

0107655001

List of active ingredient(s)
Active ingredient(s) Strength
XYLOMETAZOLINE HYDROCHLORIDE 0.1 % / W/V

Application information

Related information

Contact us

Version 3.8.0
Date modified: